Can a 12-week virtual program get latina girls moving more?

NCT ID NCT04736030

Completed Disease control Sponsor: San Diego State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests a 12-week virtual program called Conmigo, designed to help Latina girls aged 8-11 and their mothers become more physically active together. The program includes weekly 1.5-hour sessions with teaching, skill-building, and at least 30 minutes of exercise. Researchers will compare activity levels between families in the program and those on a waitlist to see if the program increases moderate-to-vigorous physical activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Conmigo behavioral program (weekly virtual sessions with physical activity, skill-building, and parenting support)
What this could lead to: If effective, this program could offer a practical, family-based way to increase physical activity and reduce obesity and chronic disease risk in Latina girls.
What could go wrong: This is a relatively small, early-stage study (158 participants) and results may not apply to all families. The program relies on self-report and short-term follow-up, so lasting benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity primary interstitial lung disease specific to childhood

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILD EXERCISE HISPANIC AMERICANS WOMEN

Contacts and locations

Locations

San Diego State University Research Foundation

San Diego, California, 92123, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.